Journal of Hepatocellular Carcinoma
Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC
By Feixiang Xiong, Xuejie Zhang, Dandan Chen and 4 others.
Abstract
Background
The incidence of metabolic dysfunction-associated steatohepatitis related hepatocellular carcinoma is increasing. However, its response to immunotherapy remains unclear. This study aimed to compare the prognosis of patients with MASH-HCC and hepatitis B virus-related HCC (HBV-HCC) under different treatment strategies.